About PRIME Medicine
Developing gene editing technology to address disease-causing mutations across a broad range of therapeutic applications
MissionTo deliver a new class of differentiated one-time curative genetic therapies to address the widest spectrum of diseases
Wow FactorPublished research in leading academic journals, including the New England Journal of Medicine, Cell, and Nature
The Real Dill ☘️
In many ways, deep science companies like PRIME Medicine and Oxford Nanopore are blurring the lines between science and magic - leveraging world-renowned scientific and academic talent to solve some of the most complex problems in disease by developing cutting edge technology. PRIME Medicine leverages the latest advances in gene-editing CRISPR technology to develop cutting edge medicines for the most challenging diseases, borne out of one of the world's leading BioTech innovation hubs of Cambridge, Massachusetts (think: Harvard, MIT, etc.). And the excitement is more than just hype - BioTech companies don't just "stumble into" successful initial public offerings (IPOs) without some semblence of scientific, financial and clinical credibility. Definitely a company to watch moving forward. (October 2023)
JonJon Lee, PT, DPT, OCS, FAAOMPT, MBA
Pickle co-founder
Company benefits
- 🔐 Health insurance
- 🏦 401K/retirement
- 🐣 Maternity/paternity leave
- 🤢 Paid sick leave
- 🏖️ Paid vacation leave
- 🏝️ Paid time off
The job search that fits your personality
Personalized matches for clinicians, for the coolest jobs in the clinic or beyond
